Taha Merghoub
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Swim Across America(US)College Medical Center(US)Parker Institute for Cancer Immunotherapy(US)Weill Cornell Medicine(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer(2015)7,863 cited
- → Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma(2014)4,353 cited
- → Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade(2016)3,055 cited
- → Neoadjuvant PD-1 Blockade in Resectable Lung Cancer(2018)2,099 cited
- → Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses(2015)1,942 cited
- → Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing(2018)1,404 cited